Non-isotopic, two-step free thyroxine immunoassay: a better measure of free thyroxine than analogue radioimmunoassay.
Plasma or serum free thyroxine (T4) was measured by a novel non-isotopic, two-step immunoassay in 373 consecutive patients attending a thyroid clinic, in whom thyroid status was categorized according to clinical findings, supported by routine thyroid function tests. The 95% confidence limit of free T4 in the euthyroid patients (n = 112) was 7-20 pmol/L. Free T4 concentrations within the reference range were found in six of 40 patients with primary hypothyroidism and nine of 182 patients with overt thyrotoxicosis, six of whom had T3 toxicosis. Serum or plasma free T4 measured by the two-step method showed improved diagnostic specificity over an analogue RIA in selected groups of euthyroid patients in whom abnormal binding of analogue T4 can affect the validity of the result. Free T4 results found by analogue RIA and the two-step method in 58 patients who were receiving thyroxine replacement therapy were similar. The between-assay precision of the two-step method was poor ranging from a coefficient of variation of 9.7% to 19.3% over a free T4 concentration range of 5.0 to 46.0 pmol/L. We conclude that the two-step methodology offers diagnostic advantages for a laboratory which receives specimens from such patients for exclusion of thyroid disease but that improved assay precision is required before it could be used in a routine situation.
Beckett
G J
GJ
University Department of Clinical Chemistry, Royal Infirmary, Edinburgh, Scotland.
Ratcliffe
W A
WA
Chapman
B
B
Wu
P
P
Rae
P W
PW
Gow
S M
SM
Toft
A D
AD
D001323:Autoantibodies / Q000276:immunology; D005260:Female; D006801:Humans; D006981:Hyperthyroxinemia / Q000175:diagnosis / Q000188:drug therapy; D007118:Immunoassay / Q000379:methods*; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000188:drug therapy; D011247:Pregnancy; D011863:Radioimmunoassay; D012016:Reference Values; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013974:Thyroxine / Q000097:blood* / Q000276:immunology / Q000627:therapeutic use; D013975:Thyroxine-Binding Proteins / Q000378:metabolism
D001323:Autoantibodies; D013975:Thyroxine-Binding Proteins; D013974:Thyroxine